REFERENCES
- Akao Y., Maruyama W., Yi H., Shamoto-Nagai M., Youdim M. B., Naoi M. An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells. Neuroscience Letters 2002; 326(2)105–108
- Chan J. Y., Cheung J. Y., Luk S. C., Wu Y. J., Pang S. F., Fung K. P. Anti-cancer and pro-apoptotic effects of an herbal medicine and Saccharomyces cerevisiae product (CKBM) on human hepatocellular carcinoma HepG2 cells in vitro and in vivo. Immunopharmacology and Immunotoxicology 2004; 26(4)597–609
- Gorina R., Petegnief V., Chamorro A., Planas A. M. AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway. Journal of Neurochemistry 2005; 92(3)505–518
- Ho J. W., Leung Y. K., Chan C. P. Herbal medicine in the treatment of cancer. Current Medicinal Chemistry Anti-cancer Agents 2002; 2(2)209–214
- Kumagai T., Müller C. I., Desmond J. C., Imai Y., Heber D., Koeffler H. P. Scutellaria baicalensis, a herbal medicine: Anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines. Leukemia Research 2007; 31(4)523–530
- Lee K. K., Kwong W. H., Chau F. T., Yew D. T., Chan W. Y. Pien Tze Huang protects the liver against carbon tetrachloride-induced damage. Pharmacology & Toxicology 2002; 91(4)185–192
- Lee H. J., Lee E. O., Rhee Y. H., Ahn K. S., Li G. X., Jiang C., Lü J., Kim S. H. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis. Carcinogenesis 2006; 27(12)2455–2463
- Liu Y., Schubert D. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. Journal of Neurochemistry 1997; 69(6)2285–2293
- Lü L., Li J., Yew D. T., Rudd J. A., Mak Y. T. Oxidative stress on the astrocytes in culture derived from a senescence accelerated mouse strain. Neurochemistry International 2008; 52: 1–2; 282–289
- Messina M., Bennink M. Soyfoods, isoflavones and risk of colonic cancer: A review of the in vitro and in vivo data. Baillière's Clinical Endocrinology and Metabolism 1998; 12(4)707–728
- Nicolini G., Miloso M., Zoia C., Di Silvestro A., Cavaletti G., Tredici G. Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: An in vitro model to assess drug neurotoxicity. Anticancer Research 1998; 18(4A)2477–2481
- Ordonez-Moran P., Larriba M. J., Pendas-Franco N., Aguilera O., Gonzalez-Sancho J. M., Munoz A. Vitamin D and cancer: An update of in vitro and in vivo data. Frontiers in Bioscience 2005; 10: 2723–2749
- Zhou S., Kestell P., Paxton J. W. Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: The experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation. Drug Metabolism Reviews 2002; 34(4)751–790